NanoAntibiotics Inc. announced the appointment of Cuong Do, MBA, as an independent member of the company's board of directors. Mr. Do is currently executive vice president, Global Strategy Group for Samsung, where he helps to set the strategic direction for Samsung Group's diverse business portfolio. As the former chief strategy officer for Merck and having successfully built and sold a biotechnology company, Mr. Do brings highly relevant experience to company. Prior to Merck he was a senior partner at McKinsey &Company, where over 17 years he helped build the healthcare, high tech and corporate finance practices.